Skip to main content
Clinical Trials/ISRCTN62452621
ISRCTN62452621
Completed
未知

A low-carbohydrate, low-energy dietary intervention for patients with type 2 diabetes in primary care: a feasibility study

niversity of Oxford0 sites33 target enrollmentApril 4, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Specialty: Primary care, Primary sub-specialty: Diabetes
Sponsor
niversity of Oxford
Enrollment
33
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30659044 protocol (added 24/02/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/31709697/ results (added 06/10/2020)

Registry
who.int
Start Date
April 4, 2018
End Date
September 30, 2019
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Participant is willing and able to give informed consent for participation in the study
  • 2\. Male or female, aged 18 years or above
  • 3\. BMI of \=30kg/m2
  • 4\. Diagnosed with type 2 diabetes
  • 5\. Patients must have undergone diabetic retinopathy screening within the last 12 months

Exclusion Criteria

  • 1\. History of, or features suspicious of, an eating disorder
  • 2\. Pregnant, breastfeeding, currently undergoing fertility treatment, or planning to become pregnant during the course of the study
  • 3\. Recent MI or CVA (\<3 months)
  • 4\. Uncontrolled ischaemic heart disease, critical ischaemia, uncontrolled hypertension, uncontrolled cardiac arrhythmia (eg inadequate rate control in AF, inadequate episode control paroxysmal AF), cardiac conduction abnormality (eg long QT syndrome)
  • 5\. Cardiac failure (Grade II New York Heart Association, and more severe)
  • 6\. Renal failure (CKD Stage 4 or 5\)
  • 7\. Active treatment for cancer (other than skin cancer treated with curative intent by local treatment only)
  • 8\. Intercurrent serious infection at time of recruitment
  • 9\. Diagnosed with a significant psychiatric disorder or substance abuse
  • 10\. Serious neurological disorder, including epilepsy

Outcomes

Primary Outcomes

Not specified

Similar Trials